656 Results

People

  1. Vickers
    Vickers
  2. Saltz
    Saltz
  3. Hudis
    Hudis
  4. Motzer
    Motzer
  5. Mao
    Mao
  6. Strong
    Strong
  7. Giralt
    Giralt
  8. Herr
    Herr
  9. Lee
    Lee
  10. Postow
    Postow

Groups

  1. Department of Medicine (293)
  2. Solid Tumor Oncology Division (193)
  3. Surgery (171)
  4. Survivorship Research (103)
  5. Population Sciences Research Program (99)
  6. Hematologic Malignancies, Division of (74)
  7. Epidemiology and Biostatistics (61)
  8. Center for Hematologic Malignancies (56)
  9. Gastrointestinal Oncology Service (52)
  10. Radiation Oncology, Department of (52)
  1. "randomized controlled trial (topic)"
Formats
  1. Journal Article (482)
  2. Review (85)
  3. Editorial (51)
  4. Correspondence (19)
  5. Guidelines (11)
  6. Research Letter (6)
  7. Conference Paper (1)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (293)
  2. Solid Tumor Oncology Division (193)
  3. Surgery (171)
  4. Survivorship Research (103)
  5. Population Sciences Research Program (99)
  6. Hematologic Malignancies, Division of (74)

More Groups

People
  1. Andrew Vickers (19)
  2. Leonard Saltz (18)
  3. Clifford Hudis (13)
  4. Robert Motzer (12)
  5. Jun Mao (11)
  6. Vivian Strong (10)

More People

Years
  1. 2025 (34)
  2. 2024 (75)
  3. 2023 (48)
  4. 2022 (47)
  5. 2021 (28)
  6. 2020 (30)

More Years

Publications
  1. Journal of Clinical Oncology (44)
  2. Journal of the National Comprehensive Cancer Network (33)
  3. European Urology (30)
  4. Annals of Surgical Oncology (18)
  5. International Journal of Radiation Oncology, Biology, Physics (12)
  6. Lancet Oncology (12)

More Publications

Publishers
  1. Elsevier Inc. (100)
  2. Elsevier Science, Inc. (70)
  3. Springer (50)
  4. American Society of Clinical Oncology (48)
  5. Oxford University Press (36)
  6. Lippincott Williams & Wilkins (34)

More Publishers

Results (656)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • REZILIENT3: Randomized phase III study of first-line zipalertinib plus chemotherapy in patients with EGFR exon 20 insertion-mutated NSCLC
    Journal Article

    Heymach, J. V.; Yu, H. A.; Besse, B.; Cheng, Y.; Tan, D. S. W.; Wei, L.; Wacheck, V.; Nishio, M.
    Future Oncology (2025)

    Fulltext@MSK | Save
  • A critical review of randomized controlled trials on topical corticosteroids for the prevention of radiation dermatitis in breast cancer
    Review

    Kuszaj, O.; Day, M.; Tse, S. S. W.; Lee, S. F.; Wang, A. J.; Bayrakdarian, S.; Vesprini, D.; Corbin, K.; Karam, I.; Choi, J. I.; more...
    Supportive Care in Cancer (2025)

    Fulltext@MSK | Save
  • The impact of cannabis on immune checkpoint inhibitor therapy: A systematic review of immunomodulatory effects of cannabis in patients with and without cancer
    Review

    Behling-Hess, C.; Simonson, G.; Salz, T.; Fleege, N.; Zylla, D.
    Supportive Care in Cancer (2025)

    Fulltext@MSK | Save
  • Landscape of subsequent therapies in perioperative immunotherapy trials across multiple cancer types
    Journal Article

    Semaan, K.; Nawfal, R.; Nally, E.; Janjigian, Y. Y.; Robert, C.; Peters, S.; Powles, T.; Choueiri, T. K.
    Lancet Oncology (2025)

    Fulltext@MSK | Save
  • Controversies in vulvar cancer: Revisiting the margin of error
    Review

    Byrne, M. E.; Leitao, M. M. Jr; Abu-Rustum, N. R.
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save
  • Anti-PD-1 treatment for MSI-H/MMRD tumors. A journey from genomics to transformative patient breakthroughs
    Editorial

    ArgileĢs, G.; Arnold, D.; Cervantes, A.
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • The landscape of clinical trials for heavily pretreated multiple myeloma: Opportunity for more randomization?
    Correspondence

    Kapur, R.; McCarron, J.; Rajeeve, S.; Mohyuddin, G. R.
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Pelvic lymph node dissection in prostate cancer: Update from a randomized clinical trial of limited versus extended dissection
    Journal Article

    Touijer, K. A.; Vertosick, E. A.; Sjoberg, D. D.; Liso, N.; Nalavenkata, S.; Melao, B.; Laudone, V. P.; Ehdaie, B.; Carver, B.; Eastham, J. A.; more...
    European Urology (2025)

    Fulltext@MSK | Save
  • Refining risk stratification of high-risk and locoregional prostate cancer: A pooled analysis of randomized trials
    Journal Article

    Ravi, P.; Xie, W.; Buyse, M.; Halabi, S.; Kantoff, P. W.; Sartor, O.; Attard, G.; Clarke, N.; D'Amico, A.; Dignam, J.; more...
    European Urology (2025)

    Fulltext@MSK | Save
  • Addition of elotuzumab to backbone treatment regimens for multiple myeloma: An updated meta-analysis of randomized clinical trials
    Journal Article

    Costa, B. A.; Costa, T. A.; Chagas, G. C. L.; Mouhieddine, T. H.; Richter, J.; Usmani, S. Z.; Mailankody, S.; Rajeeve, S.; Hashmi, H.
    Clinical Lymphoma, Myeloma and Leukemia (2025)

    Fulltext@MSK | Save